REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio de Citologia y Patologia Citopat Sas (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio de Citologia y Patologia Citopat Sas Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio de Citologia y Patologia Citopat Sas is based in Colombia, with the head office in Rionegro. The enterprise currently operates in the Diagnostic Imaging Centers sector. It was first established on January 18, 2011. There are currently 17 (2023) people employed by Laboratorio de Citologia y Patologia Citopat Sas. In its most recent financial highlights, the company reported a net sales revenue increase of 26.41% in 2023. Its’ total assets recorded a growth of 8.51%. The net profit margin of Laboratorio de Citologia y Patologia Citopat Sas decreased by 28.62% in 2023.

Headquarters
Cl 38 Cr 54A 35 Cs 204
Rionegro; Antioquia;

Contact Details: Purchase the Laboratorio de Citologia y Patologia Citopat Sas report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio de Citologia y Patologia Citopat Sas report to view the information.
Outstanding Shares:
Purchase the Laboratorio de Citologia y Patologia Citopat Sas report to view the information.
Incorporation Date:
January 18, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio de Citologia y Patologia Citopat Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
26.41%
Total operating revenue
26.41%
Operating profit (EBIT)
14.18%
EBITDA
17.31%
Net Profit (Loss) for the Period
-55.78%
Total assets
8.51%
Total equity
17.66%
Operating Profit Margin (ROS)
-2.37%
Net Profit Margin
-28.62%
Return on Equity (ROE)
-24.03%
Debt to Equity Ratio
-4.03%
Quick Ratio
1.65%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?